GLP3

Reta (GLP3)

An investigational triple-receptor agonist and one of the most closely watched compounds in modern metabolic research. Each Vitalyx Bio vial contains 10 mg of Reta as a lyophilized powder, supplied strictly for in-vitro and laboratory research.

About Reta

Reta is a synthetic peptide engineered to act on three receptors at once — GLP-1, GIP, and glucagon. This triple-agonist design is what sets it apart from single- and dual-agonist peptides and has made it a frequent subject in research on energy balance and metabolic signaling.

Research Context

In laboratory and preclinical models, Reta is investigated for its role in glucose regulation, lipid metabolism, and energy homeostasis. It is supplied for research purposes only and is not approved for any therapeutic use.

Storage & Handling

Keep the sealed, lyophilized vial cool, dry, and out of light, where it remains stable long-term before reconstitution. Once reconstituted, store refrigerated at 2–8 °C and away from freeze–thaw cycles, and defer to your laboratory’s standard handling protocols.

FAQ

What form does it ship in?
A lyophilized (freeze-dried) powder, for stability in storage and transit prior to reconstitution.

How should it be stored?
Sealed, cool, dry, and dark before reconstitution; refrigerated at 2–8 °C afterward, with no freeze–thaw cycling.

Is this for human use?
No. Vitalyx Bio supplies this material strictly for laboratory and in-vitro research. It is not for human or animal consumption.

For laboratory and research use only. Not for human or veterinary consumption. These statements have not been evaluated by the U.S. Food and Drug Administration. Vitalyx Bio is a chemical supplier and is not a compounding pharmacy or outsourcing facility as defined under Sections 503A/503B of the Federal Food, Drug, and Cosmetic Act. Products are not intended to diagnose, treat, cure, or prevent any disease.